Medtronic Petitions FCC To Expand Medical Testing License Eligibility
This article was originally published in The Gray Sheet
Executive Summary
In a petition to the Federal Communications Commission, Medtronic asked the agency to expand medical testing license eligibility to sponsors of clinical trials, as well as clarify its policy on manufacturers recovering costs for clinical studies.
You may also be interested in...
FDA Aims To Stay Ahead Of Wireless Technology Upgrades With Final Guidance
A final guidance released last week attempts to adopt a flexible approach to regulating the rapidly evolving category of devices that employ radiofrequency wireless technology.
Regulatory News In Brief
IMDRF releases three new proposed guidance documents. FDA is accepting comments on its plans to accept electronic submissions for device recalls. More regulatory news.
FCC Simplifies Process To Access Wireless Spectrum For Device Clinical Trials
A Federal Communications Commission regulation establishes a medical testing license for health care facilities wishing to host human trials for medical devices with wireless capability.